Approval · Notice of Compliance 29164 · 2022
BIMEPRAZOL: Notice of Compliance 29164
Issued October 11, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29164
- Date
- October 11, 2022
- Company
- Bimeda-MTC Animal Health Inc.Cambridge, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- GASTROGARD
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIMEPRAZOL | 02531674 | Marketed |
Medicinal ingredients
- OMEPRAZOLE 37 PER